Apr 25 |
UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting
|
Apr 23 |
UNITY Biotechnology Announces Extension of Phase 2b ASPIRE Clinical Study Evaluating UBX1325 in DME
|
Apr 17 |
Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
|
Apr 15 |
Unity Biotechnology GAAP EPS of -$0.28 beats by $0.49
|
Apr 15 |
UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
|
Feb 6 |
New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss
|
Dec 29 |
10 Supplements for Longevity and Antiaging: Expert Recommendations
|
Dec 12 |
UNITY Biotechnology Doses First Patients in Phase 2 ASPIRE Study of UBX1325 in DME
|
Dec 6 |
Unity Biotechnology files to sell 2.27M shares of common stock for holders
|
Nov 16 |
Wedbush upgrades Unity Biotechnology to outperform, cites cash runway
|